Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Ethan Basch, Deborah Schrag, Bryce B. Reeve et al.|JNCI Journal of the National Cancer Institute|2014Cited by 1.1k
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Amylou C. Dueck, Ethan Basch, Tito R. Mendoza et al.|JAMA Oncology|2015Cited by 1k
Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone MetastasesAndrew L. Himelstein, Charles L. Shapiro, Mario R. Velasco et al.|JAMA|2017Cited by 357
Systematic review of barriers and facilitators to clinical trial enrollment among adolescents and young adults with cancer: Identifying opportunities for interventionElizabeth J. Siembida, Michael Roth, Holli A. Loomans‐Kropp et al.|Cancer|2019Cited by 86
Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology ProgramMichael Roth, David R. Freyer, Ann M. O’Mara et al.|Journal of Oncology Practice|2016Cited by 77